ZHAO Bai-yun, LI Yue-yue, ZHU Zhen-yu, ZHAO Liang, GE Meng, ZHANG Guo-qing, CHAI Yi-feng. Analysis of toxic ingredients of Xiao Chai Hu Tang[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(6): 454-458. doi: 10.3969/j.issn.1006-0111.2013.06.016
Citation:
|
ZHAO Bai-yun, LI Yue-yue, ZHU Zhen-yu, ZHAO Liang, GE Meng, ZHANG Guo-qing, CHAI Yi-feng. Analysis of toxic ingredients of Xiao Chai Hu Tang[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(6): 454-458. doi: 10.3969/j.issn.1006-0111.2013.06.016
|
Analysis of toxic ingredients of Xiao Chai Hu Tang
- 1.
Department of Pharmacy, Hangzhou Normal University Affiliated Hospital, Hangzhou 310000, China
- 2.
Department of Pharmacy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China
- 3.
School of Pharmacy, Second Millitary Medical University, Shanghai 200433, China
- Received Date: 2012-09-08
- Rev Recd Date:
2012-12-08
-
Abstract
Objective To determine whether Xiao Chai Hu Tang have liver toxicity and the sources of toxicity. Methods HPLC-TOF/MS method and the MTT were used to assay the Xiao Chai Hu Tang chemical composition and the survival of SMMC-7721 cells, respectively. Then the stepwise multiple linear regression was used to analysis the chemical composition of Xiao Chai Hu Tang which affected SMMC-7721 cells survival. Results The possible toxic component were found from Scutellaria:X3, chrysin-8-C-β-D-glucose the pyrano base-6-C-α in-L-Arab pyran-glucosidase or its isomers. Conclusion The method initially found potentially toxic constituents of Xiao Chai Hu Tang, which provided a research base for Attenuated compatibility, in order to optimize the prescription, develop the preparation process of science, and improve the quality of the preparations.
-
References
[1]
|
陆婷婷,赵国平.小柴胡汤防治肝病机制研究进展[J].世界华人消化杂志,2008,16(9):971. |
[2]
|
尹丽荣,陈泽雄.小柴胡汤治疗肝癌研究进展[J].中成药,2008,30(4):583. |
[3]
|
杜矗森,黄秀深.小柴胡汤及组分抗肿瘤作用研究与分析[J].河北中医,2009,31(6):948. |
[4]
|
金 航.日本汉方药制剂副作用分析[J].国外医学中医中药分册,1997,19(3):62. |
[5]
|
陈 静. 浅论中药药物性肝病[J].湖北中医杂志,1999,21(5):202. |
[6]
|
Melchart D,Linde K,Weidenhammer W,et al. Liver enzyme elevation in patients treated with traditional Chinese medicine[J]. JAMA,1999,282:28. |
[7]
|
Chitturi S,Farrell GC. Herbal hepatotoxicity:An expanding but poorly defind problem[J]. J Gastroenterol Hepatol, 2000,15:1093. |
[8]
|
Thomas D. Schiano, MD. Liver injury from herbs and other botanicals[J].Clin Liv Dis,1998,2(3):607. |
[9]
|
彭龙玲,杨亚斯,曹 毓,等.小柴胡汤提取物灌胃给药的长期毒性实验研究[J].时珍国医国药,2003,14(9):517. |
[10]
|
孙振球.医学统计学[M].北京:人民卫生出版社,2010:245. |
[11]
|
刘晓帆,娄子洋,朱臻宇,等.采用HPLC-TOF/MS对中药复方小柴胡汤中化学成分的快速分析鉴别[J].第二军医大学学报,2009, 8:941. |
[12]
|
戈 萌,柴逸峰,季红光,等.不同配伍组方小柴胡汤的人肝细胞毒性体外检测[J]. 第二军医大学学报,2007,11:1266. |
[13]
|
赵 翔,陈 希,李常虹,等.白杨素对人肝癌BEL-7402细胞表面超微结构和蛋白质磷酸化及相关通路的影响[J]. 中国组织工程研究与临床康复,2011, 15(6):1050. |
[14]
|
姜金生,韦英杰,贾晓斌,等.白杨素及其衍生物的药理作用和构效关系研究进展[J].中草药2011,42(11):2345. |
[15]
|
韦 敏,刘华钢,刘丽敏,等.白花丹素的体外肝毒性研究[J].时珍国医国药2011,42(11):1312. |
-
-
Proportional views
-